234 related articles for article (PubMed ID: 22805420)
1. Genetically elevated bilirubin and risk of ischaemic heart disease: three Mendelian randomization studies and a meta-analysis.
Stender S; Frikke-Schmidt R; Nordestgaard BG; Grande P; Tybjaerg-Hansen A
J Intern Med; 2013 Jan; 273(1):59-68. PubMed ID: 22805420
[TBL] [Abstract][Full Text] [Related]
2. Milk intake is not associated with ischaemic heart disease in observational or Mendelian randomization analyses in 98,529 Danish adults.
Bergholdt HK; Nordestgaard BG; Varbo A; Ellervik C
Int J Epidemiol; 2015 Apr; 44(2):587-603. PubMed ID: 26085675
[TBL] [Abstract][Full Text] [Related]
3. Nonfasting glucose, ischemic heart disease, and myocardial infarction: a Mendelian randomization study.
Benn M; Tybjaerg-Hansen A; McCarthy MI; Jensen GB; Grande P; Nordestgaard BG
J Am Coll Cardiol; 2012 Jun; 59(25):2356-65. PubMed ID: 22698489
[TBL] [Abstract][Full Text] [Related]
4. Extreme bilirubin levels as a causal risk factor for symptomatic gallstone disease.
Stender S; Frikke-Schmidt R; Nordestgaard BG; Tybjærg-Hansen A
JAMA Intern Med; 2013 Jul; 173(13):1222-8. PubMed ID: 23753274
[TBL] [Abstract][Full Text] [Related]
5. No evidence that genetically reduced 25-hydroxyvitamin D is associated with increased risk of ischaemic heart disease or myocardial infarction: a Mendelian randomization study.
Brøndum-Jacobsen P; Benn M; Afzal S; Nordestgaard BG
Int J Epidemiol; 2015 Apr; 44(2):651-61. PubMed ID: 25981321
[TBL] [Abstract][Full Text] [Related]
6. Pentanucleotide repeat polymorphism, lipoprotein(a) levels, and risk of ischemic heart disease.
Kamstrup PR; Tybjaerg-Hansen A; Steffensen R; Nordestgaard BG
J Clin Endocrinol Metab; 2008 Oct; 93(10):3769-76. PubMed ID: 18682504
[TBL] [Abstract][Full Text] [Related]
7. Elevated remnant cholesterol causes both low-grade inflammation and ischemic heart disease, whereas elevated low-density lipoprotein cholesterol causes ischemic heart disease without inflammation.
Varbo A; Benn M; Tybjærg-Hansen A; Nordestgaard BG
Circulation; 2013 Sep; 128(12):1298-309. PubMed ID: 23926208
[TBL] [Abstract][Full Text] [Related]
8. TRIB1 and GCKR polymorphisms, lipid levels, and risk of ischemic heart disease in the general population.
Varbo A; Benn M; Tybjærg-Hansen A; Grande P; Nordestgaard BG
Arterioscler Thromb Vasc Biol; 2011 Feb; 31(2):451-7. PubMed ID: 21071687
[TBL] [Abstract][Full Text] [Related]
9. Genetically reduced antioxidative protection and increased ischemic heart disease risk: The Copenhagen City Heart Study.
Juul K; Tybjaerg-Hansen A; Marklund S; Heegaard NH; Steffensen R; Sillesen H; Jensen G; Nordestgaard BG
Circulation; 2004 Jan; 109(1):59-65. PubMed ID: 14662715
[TBL] [Abstract][Full Text] [Related]
10. LCAT, HDL cholesterol and ischemic cardiovascular disease: a Mendelian randomization study of HDL cholesterol in 54,500 individuals.
Haase CL; Tybjærg-Hansen A; Qayyum AA; Schou J; Nordestgaard BG; Frikke-Schmidt R
J Clin Endocrinol Metab; 2012 Feb; 97(2):E248-56. PubMed ID: 22090275
[TBL] [Abstract][Full Text] [Related]
11. Myocardial infarction and ischemic heart disease in overweight and obesity with and without metabolic syndrome.
Thomsen M; Nordestgaard BG
JAMA Intern Med; 2014 Jan; 174(1):15-22. PubMed ID: 24217719
[TBL] [Abstract][Full Text] [Related]
12. Circulating total bilirubin and risk of non-alcoholic fatty liver disease in the PREVEND study: observational findings and a Mendelian randomization study.
Kunutsor SK; Frysz M; Verweij N; Kieneker LM; Bakker SJL; Dullaart RPF
Eur J Epidemiol; 2020 Feb; 35(2):123-137. PubMed ID: 31773475
[TBL] [Abstract][Full Text] [Related]
13. Plasma levels of apolipoprotein E and risk of ischemic heart disease in the general population.
Rasmussen KL; Tybjærg-Hansen A; Nordestgaard BG; Frikke-Schmidt R
Atherosclerosis; 2016 Mar; 246():63-70. PubMed ID: 26761769
[TBL] [Abstract][Full Text] [Related]
14. Elevated Lipoprotein(a) Does Not Cause Low-Grade Inflammation Despite Causal Association With Aortic Valve Stenosis and Myocardial Infarction: A Study of 100,578 Individuals from the General Population.
Langsted A; Varbo A; Kamstrup PR; Nordestgaard BG
J Clin Endocrinol Metab; 2015 Jul; 100(7):2690-9. PubMed ID: 25938632
[TBL] [Abstract][Full Text] [Related]
15. PCSK9 R46L, low-density lipoprotein cholesterol levels, and risk of ischemic heart disease: 3 independent studies and meta-analyses.
Benn M; Nordestgaard BG; Grande P; Schnohr P; Tybjaerg-Hansen A
J Am Coll Cardiol; 2010 Jun; 55(25):2833-42. PubMed ID: 20579540
[TBL] [Abstract][Full Text] [Related]
16. Genetically elevated apolipoprotein A-I, high-density lipoprotein cholesterol levels, and risk of ischemic heart disease.
Haase CL; Tybjærg-Hansen A; Grande P; Frikke-Schmidt R
J Clin Endocrinol Metab; 2010 Dec; 95(12):E500-10. PubMed ID: 20826588
[TBL] [Abstract][Full Text] [Related]
17. Fibrinogen and coronary heart disease: test of causality by 'Mendelian randomization'.
Keavney B; Danesh J; Parish S; Palmer A; Clark S; Youngman L; Delépine M; Lathrop M; Peto R; Collins R
Int J Epidemiol; 2006 Aug; 35(4):935-43. PubMed ID: 16870675
[TBL] [Abstract][Full Text] [Related]
18. Endogenous androgen exposures and ischemic heart disease, a separate sample Mendelian randomization study.
Zhao JV; Schooling CM
Int J Cardiol; 2016 Nov; 222():940-945. PubMed ID: 27526363
[TBL] [Abstract][Full Text] [Related]
19. Serum total bilirubin levels and coronary heart disease--Causal association or epiphenomenon?
Kunutsor SK
Exp Gerontol; 2015 Dec; 72():63-6. PubMed ID: 26408227
[TBL] [Abstract][Full Text] [Related]
20. Bilirubin and risk of ischemic heart disease in Korea: a two-sample Mendelian randomization study.
Jeon C; Lee JY; Lee SJ; Jung KJ; Kimm H; Jee SH
Epidemiol Health; 2019; 41():e2019034. PubMed ID: 31319653
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
